IMPORTANT DATES:
- The deadline for submission of Original Research and Clinical Pharmacy Forum abstracts is January 21, 2019.
- The deadline for submission of Research-in-Progress abstracts is February 27, 2019.
To review the complete submission instructions, guidelines, and review criteria, or to submit an abstract, visit the ACCP website.
All investigators in the field of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to be considered for presentation at ACCP Updates in Therapeutics® 2019. ACCP’s April meeting will deliver specialty certification preparatory review and recertification courses, ACCP Academy programming, the Patient-Centered Team-Based Practice Forum, ACCP's Emerge from the Crowd program, and scientific poster presentations. Submit an abstract and plan to join us April 27–28, 2019, in St. Louis, Missouri. All poster presenters must be registered for one of the meeting's programs (i.e., Updates in Therapeutics, ACCP Academy, Patient-Centered Team-Based Practice Forum, or Emerge from the Crowd [students only]).
All abstracts accepted for presentation and presented, except for “Encore” and “Research-in-Progress” presentations, will have full-text abstracts published online in an official journal of ACCP. Only the abstract title, authors, and original citation will be published for “Encore” presentations. All accepted abstracts will be published full-text in the ACCP Meeting App. Posters from all categories will be distributed across the poster display sessions/days.
ABSTRACT CATEGORIES:
Original Research: Abstracts must summarize quantitative or qualitative findings from completed research. Basic, clinical, translational, dissemination/implementation, or educational research are examples of acceptable research. Topics should be relevant to a clinical pharmacy audience and may include research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are invited. Encore submissions are also welcome.
Clinical Pharmacy Forum: Abstracts must describe the delivery, justification, documentation, adaptability, and impact/significance of innovative clinical pharmacy services. Abstracts that address comprehensive medication management (CMM) implementation (see www.accp.com/cmm), describe components of the ACCP Standards of Practice for Clinical Pharmacists, and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component.
Research-in-Progress: Submission guidelines are the same as for an Original Research abstract except that the research effort is ongoing at the time of abstract submission.
Encore Presentations: Submission and evaluation criteria are the same as for the Original Research category, except that the same abstract was presented elsewhere or published in abstract form only before this meeting. Abstracts submitted for Encore Presentations must not be modified from the previously presented/published version. This includes the title, authors, and abstract body. The presenting author may differ, but he or she must be an author on the original abstract.
IMPORTANT DATES:
To review the complete submission instructions, guidelines, and review criteria, or to submit an abstract, visit the ACCP website.